Knopp

Knopp Neurosciences (www.knoppneurosciences.com) is a biotechnology company developing a novel biomarker to diagnose and treat ALS. The company has exclusively licensed a compound that may not only provide a treatment for ALS but also may have applications in treating Parkinson's disease, traumatic brain injury, macular degeneration, diabetes and cardiac injury.